International Point of Care Inc. | Fortis Life Sciences

International Point of Care Inc. | Fortis Life Sciences

Founded: 2008

Headquarter: Canada

Industries: Biotechnology

Slogan: Providing biological reagents, diagnostic kits, clinical trials, and comprehensive laboratory testing services.

International Point of Care Incorporated (IPOC), based in Toronto, Canada, is a leading provider of innovative solutions for the in-vitro diagnostic industry and research and development community. With a strong focus on rapid point-of-care testing, IPOC offers contract IVD manufacturing, lateral flow components (including Primecare blood separation membrane), and custom lyophilization services (including lyophilized beaded reagents, LBR) to meet the diverse needs of the global healthcare clientele. Their 36,000 sq ft manufacturing facility is an FDA-registered medical device establishment (cGMP-compliant) and ISO 13485:2016 certified. Their products and services include fine biochemicals (recombinant proteins, monoclonal, and polyclonal antibodies), proprietary asymmetric blood separation membranes for application in point-of-care diagnostic tests, contract lyophilization services to address commercial-scale demand, and contract manufacturing for lateral flow tests including formulation, production assembly, and packaging. With a strong foothold in the biotechnology sector and a robust infrastructure, IPOC holds significant potential for growth and innovation, making it an attractive prospect for venture capital investment in the biotech space.